Golimumab (GOL)

( DrugBank: Golimumab / KEGG DRUG: Golimumab )

1 disease

ID	Disease name (Link within this page)	Number of trials
56	Behcet disease	1

56. Behcet disease

Clinical trials : 81 / Drugs : 107 - (DrugBank : 30) / Drug target genes : 36 - Drug target pathways : 116

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04218565 (ClinicalTrials.gov)	February 15, 2020	8/12/2019	Golimumab for the Treatment of Refractory Behcet's Uveitis	Efficacy and Safety of Golimumab in the Treatment of Refractory Uveitis in Patients With Behcet's Di ...	Behcet Syndrome;Uveitis	Biological: Golimumab (GOL)	Wenjie Zheng	NULL	Recruiting	18 Years	65 Years	All	9	Phase 2	China